GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Seoul Pharma Co Ltd (XKRX:018680) » Definitions » Cyclically Adjusted PS Ratio

Seoul Pharma Co (XKRX:018680) Cyclically Adjusted PS Ratio : 0.58 (As of Jun. 04, 2025)


View and export this data going back to 2000. Start your Free Trial

What is Seoul Pharma Co Cyclically Adjusted PS Ratio?

As of today (2025-06-04), Seoul Pharma Co's current share price is ₩3475.00. Seoul Pharma Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ₩6,002.95. Seoul Pharma Co's Cyclically Adjusted PS Ratio for today is 0.58.

The historical rank and industry rank for Seoul Pharma Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

XKRX:018680' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.51   Med: 1.07   Max: 2.65
Current: 0.59

During the past years, Seoul Pharma Co's highest Cyclically Adjusted PS Ratio was 2.65. The lowest was 0.51. And the median was 1.07.

XKRX:018680's Cyclically Adjusted PS Ratio is ranked better than
83.47% of 738 companies
in the Drug Manufacturers industry
Industry Median: 2.155 vs XKRX:018680: 0.59

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Seoul Pharma Co's adjusted revenue per share data for the three months ended in Mar. 2025 was ₩1,098.851. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₩6,002.95 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Seoul Pharma Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Seoul Pharma Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Seoul Pharma Co Cyclically Adjusted PS Ratio Chart

Seoul Pharma Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.70 1.23 0.79 0.62 0.55

Seoul Pharma Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.57 0.52 0.63 0.55 0.51

Competitive Comparison of Seoul Pharma Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Seoul Pharma Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Seoul Pharma Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Seoul Pharma Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Seoul Pharma Co's Cyclically Adjusted PS Ratio falls into.


;
;

Seoul Pharma Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Seoul Pharma Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=3475.00/6002.95
=0.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Seoul Pharma Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Seoul Pharma Co's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=1098.851/122.5900*122.5900
=1,098.851

Current CPI (Mar. 2025) = 122.5900.

Seoul Pharma Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 1,712.145 100.051 2,097.855
201509 1,473.131 100.111 1,803.913
201512 1,705.626 100.220 2,086.329
201603 1,459.014 100.561 1,778.629
201606 1,661.025 100.791 2,020.276
201609 1,331.185 101.461 1,608.398
201612 831.509 101.561 1,003.676
201703 1,288.661 102.851 1,535.985
201706 1,419.533 102.611 1,695.920
201709 1,426.115 103.491 1,689.309
201712 345.937 102.991 411.769
201803 1,359.031 104.101 1,600.407
201806 1,370.448 104.130 1,613.394
201809 1,133.846 105.651 1,315.641
201812 1,286.784 104.351 1,511.699
201903 1,680.319 104.491 1,971.371
201906 1,309.403 104.881 1,530.495
201909 1,626.671 105.200 1,895.561
201912 1,830.528 105.121 2,134.719
202003 1,191.733 105.354 1,386.699
202006 1,552.277 105.112 1,810.393
202009 2,503.981 106.198 2,890.489
202012 908.250 105.765 1,052.730
202103 941.887 107.357 1,075.530
202106 1,190.312 107.579 1,356.407
202109 1,257.594 108.759 1,417.521
202112 1,353.495 109.676 1,512.859
202203 1,455.718 111.848 1,595.527
202206 1,321.279 114.072 1,419.938
202209 1,354.889 114.715 1,447.896
202212 1,260.151 115.179 1,341.231
202303 1,075.417 116.507 1,131.562
202306 1,072.320 117.182 1,121.807
202309 1,169.153 118.964 1,204.793
202312 1,138.869 118.837 1,174.835
202403 1,155.666 120.123 1,179.398
202406 1,087.305 120.007 1,110.705
202409 1,162.479 120.861 1,179.107
202412 1,201.417 121.135 1,215.846
202503 1,098.851 122.590 1,098.851

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Seoul Pharma Co  (XKRX:018680) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Seoul Pharma Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Seoul Pharma Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Seoul Pharma Co Business Description

Traded in Other Exchanges
N/A
Address
21, Banpo-daero, Seocho-gu, Seoul, KOR, 06710
Seoul Pharma Co Ltd is engaged in manufacturing and distribution of pharmaceuticals products in South Korea. Its products portfolio consists of drugs for the cardiovascular system, respiratory system, and digestive system, drugs for hypertension, antipyretics, drugs for skin disease, drugs for a cough as well as ointments, among others.

Seoul Pharma Co Headlines

No Headlines